feed,title,long_url,short_url
Investors,AstraZeneca's $80 Billion Ambition Just Got A Big Infusion With New Hypertension Results,https://www.investors.com/news/technology/astrazeneca-hypertension-blood-pressure-baxdrostat-mineralys-therapeutics/,
